Highlander Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.66M Sell
16,819
-275
-2% -$43.8K 0.91% 23
2023
Q4
$2.68M Sell
17,094
-100
-0.6% -$15.3K 0.95% 20
2023
Q3
$2.68M Buy
17,194
+3,219
+23% +$531K 1.05% 17
2023
Q2
$2.31M Sell
13,975
-550
-4% -$88.8K 1.07% 18
2023
Q1
$2.25M Hold
14,525
1.1% 18
2022
Q4
$2.57M Sell
14,525
-2,200
-13% -$380K 1.34% 15
2022
Q3
$2.73M Sell
16,725
-2,400
-13% -$406K 1.57% 12
2022
Q2
$3.4M Buy
19,125
+50
+0.3% +$8.91K 1.83% 9
2022
Q1
$3.38M Hold
19,075
1.58% 13
2021
Q4
$3.26M Sell
19,075
-300
-2% -$49.1K 1.51% 13
2021
Q3
$3.13M Sell
19,375
-250
-1% -$42.7K 1.59% 12
2021
Q2
$3.23M Hold
19,625
1.62% 11
2021
Q1
$3.23M Buy
19,625
+125
+0.6% +$20.2K 1.69% 12
2020
Q4
$3.07M Sell
19,500
-50
-0.3% -$7.38K 1.71% 10
2020
Q3
$2.91M Hold
19,550
1.76% 9
2020
Q2
$2.75M Hold
19,550
1.73% 10
2020
Q1
$2.56M Buy
19,550
+150
+0.8% +$21.3K 1.84% 9
2019
Q4
$2.83M Sell
19,400
-150
-0.8% -$20.3K 1.63% 9
2019
Q3
$2.53M Buy
19,550
+1,720
+10% +$227K 1.56% 10
2019
Q2
$2.48M Hold
17,830
1.51% 9
2019
Q1
$2.49M Sell
17,830
-1,155
-6% -$155K 1.54% 10
2018
Q4
$2.44M Buy
18,985
+320
+2% +$44.6K 1.6% 8
2018
Q3
$2.58M Hold
18,665
1.43% 10
2018
Q2
$2.27M Buy
18,665
+1,360
+8% +$170K 1.28% 11
2018
Q1
$2.16M Buy
17,305
+9,375
+118% +$1.27M 1.29% 11
2017
Q4
$1.11M Hold
7,930
0.81% 24
2017
Q3
$1.03M Sell
7,930
-100
-1% -$13.3K 0.8% 22
2017
Q2
$1.07M Hold
8,030
0.84% 19
2017
Q1
$1M Hold
8,030
0.82% 22
2016
Q4
$925K Sell
8,030
-600
-7% -$69.3K 0.8% 23
2016
Q3
$1.02M Hold
8,630
0.91% 18
2016
Q2
$1.05M Hold
8,630
0.96% 14
2016
Q1
$934K Buy
8,630
+200
+2% +$20.7K 0.87% 20
2015
Q4
$866K Sell
8,430
-151
-2% -$15.2K 0.8% 25
2015
Q3
$801K Buy
8,581
+2
+0% +$193 0.76% 28
2015
Q2
$836K Buy
8,579
+2
+0% +$200 0.75% 28
2015
Q1
$863K Buy
8,577
+1
+0% +$102 0.75% 29
2014
Q4
$897K Buy
8,576
+701
+9% +$73.9K 0.77% 28
2014
Q3
$839K Sell
7,875
-148
-2% -$15.3K 0.79% 27
2014
Q2
$839K Sell
8,023
-224
-3% -$22.6K 0.76% 28
2014
Q1
$810K Buy
8,247
+2
+0% +$185 0.76% 30
2013
Q4
$755K Buy
8,245
+1
+0% +$92 0.71% 29
2013
Q3
$715K Sell
8,244
-1,098
-12% -$98.5K 0.72% 29
2013
Q2
$802K Buy
+9,342
New +$793K 0.85% 19

Other funds holding JNJ

Highlander Capital Management's JNJ Position: Q1 2024 in Review

Highlander Capital Management reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q1 2024, selling an estimated $43.8K and leaving 16,819 shares worth $2.66M. The position accounts for 0.91% of the portfolio, ranked #23.

Highlander Capital Management first reported a position in JNJ in Q2 2013 and has held it in 44 quarters since. The position peaked at $3.4M in Q2 2022. 3,849 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.

  • Highlander Capital Management held 16,819 shares of Johnson & Johnson worth $2.66M as of Q1 2024.
  • Highlander Capital Management sold 275 Johnson & Johnson shares in Q1 2024, an estimated $43.8K.
  • Johnson & Johnson made up 0.91% of Highlander Capital Management's portfolio in Q1 2024, its #23 holding.
  • Highlander Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 44 quarters since.
  • Highlander Capital Management's Johnson & Johnson position peaked at $3.4M in Q2 2022.
  • 3,849 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.